Physician profile
Jesse Feuerstein
NPI 1902467715
$6,052.67
in general payments reported to CMS, 2019-2025
9 companies · $3,683 in 2025
The $3,683 reported for 2025 was more than what 94% of Oral and Maxillofacial Pathology providers received nationally (typical 2025 total: $90.97).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $299 · 2021: $1,182 · 2022: $90.54 · 2023: $377 · 2024: $221 · 2025: $3,683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,058 · Food and Beverage: $1,898 · Education: $225 · Gift: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,057.60 |
| Food and Beverage | $1,897.54 |
| Education | $225.00 |
| Gift | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $4,081.35 | 2023-2025 | |
| Medical Device Business Services, INC. | $1,466.89 | 2020-2021 | |
| Depuy Synthes Sales INC. | $220.89 | 2022-2023 | Trumatch |
| Zimmer Biomet Holdings, INC. | $153.81 | 2019-2023 | Omnimax |
| Stryker Corporation | $57.87 | 2019 | |
| Biohorizons Implant Systems INC. | $24.92 | 2024 | Biohorizons |
| Zimvie INC. | $21.88 | 2024 | |
| Baxter Healthcare | $13.66 | 2020 | |
| Axogen | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Feuerstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.